Skip to main content
# Title Type of news Date Link of news
128 Safety Signal of Olmesartan and Risk of Drug Induced Liver Injury Signal
127 Safety Signal of Everolimus and Risk of Osteonecrosis of Jaw Signal
126 Safety Signal of Docetaxel and Risk of Rhabdomyolysis Signal
125 Safety Signal of Colistin and Risk of Stevens - Johnson Syndrome Signal
124 Safety Signal of Ciclosporin and Risk of Respiratory Failure Signal
123 Safety Signal of Secukinumab and the Risk of Facial Paralysis Signal
122 Safety Signal of Rituximab and the Risk of Increased Aspartate Aminotransferase (AST) Signal
121 Safety Signal of Dutasteride and the Risk of Diabetes Mellitus Signal
120 Safety Signal of Olaparib and the Risk of Pneumocystis Jirovecii Pneumonia Signal
119 Safety Signal of Pembrolizumab and the Risk of Cholestasis Signal
Displaying 41 - 50 of 170